Connie's Patient Story
“My cancer is a rare one, one that only affects 3 out of one million people each year in the U.S. When my cancer came back following chemotherapy, I was thankful to have access to a clinical trial, which is now helping to control my cancer.”
Connie, a 63-year-old Lakewood, Colo. resident was diagnosed with Waldenstrom’s Macroglobulinemia, a type of non-Hodgkin lymphoma, in 2011. This rare cancer makes large amounts of an abnormal protein called macroglobulin that can crowd out normal, healthy cells and make patients feel tired, weak and can also make it harder to fight infections.
After traditional treatment with several rounds of chemotherapy in 2011, Connie’s cancer appeared again in 2014. Given her relapse, Connie’s medical oncologist referred her to Jeffrey Matous, MD, the medical director of the Colorado Blood Cancer Institute, a Sarah Cannon Blood Cancer Network member, so that she could access a clinical trial being studied to treat her unusual cancer. Connie enrolled in the clinical trial in 2014 and continues to see positive results in controlling her cancer today.